Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation.

@article{Atkins2002EffectsOL,
  title={Effects of long-term administration of enalapril on clinical indicators of renal function in dogs with compensated mitral regurgitation.},
  author={Clarke E Atkins and William A. Brown and Julie R Coats and Mary Ann Crawford and Teresa C DeFrancesco and Joel Edwards and Philip R Fox and Bruce W Keene and Linda B. Lehmkuhl and M.W. Luethy and Kathryn M. Meurs and J Petrie and Frank S. Pipers and Steven L. Rosenthal and Jennifer A Sidley and J Straus},
  journal={Journal of the American Veterinary Medical Association},
  year={2002},
  volume={221 5},
  pages={
          654-8
        }
}
OBJECTIVE To determine the effect of long-term administration of enalapril on renal function in dogs with severe, compensated mitral regurgitation. DESIGN Randomized controlled trial. ANIMALS 139 dogs with mitral regurgitation but without overt signs of heart failure. PROCEDURE Dogs were randomly assigned to be treated with enalapril (0.5 mg/kg [0.23 mg/lb], PO, q 24 h) or placebo, and serum creatinine and urea nitrogen concentrations were measured at regular intervals for up to 26 months… Expand
Long-term tolerability of benazepril in dogs with congestive heart failure.
  • J. Pouchelon, J. King, +18 authors G. Strehlau
  • Medicine
  • Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology
  • 2004
TLDR
Benazepril was well tolerated during long-term therapy in dogs with CHF and no specific precautions appear to be necessary regarding plasma alanine aminotransferase, creatinine, potassium and urea, although differences approached statistical significance for potassium in some sub-groups. Expand
Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency.
TLDR
Chronic enalapril treatment of dogs with naturally occurring, moderate to severe MR significantly delayed onset of CHF, compared with placebo, on the basis of number ofCHF-free days, number of dogs free of CHFs at days 500 and study end, and increased time to a combined secondary endpoint of CHf-all-cause death. Expand
Safety of spironolactone in dogs with chronic heart failure because of degenerative valvular disease: a population-based, longitudinal study.
TLDR
Dogs with heart failure receiving spironolactone in addition to conventional treatment are not at a higher risk for AEs, death caused by cardiac disease, renal disease, or both, hyperkalemia, or azotemia. Expand
Effects of enalapril in cats with pressure overload-induced left ventricular hypertrophy
TLDR
Results suggest that, in a pressure overload model, enalapril (0.5 mg/kg, sid) inhibits cardiac hypertrophy, reduces blood pressure, and does not adversely affect renal function. Expand
Effect of benazepril on survival and cardiac events in dogs with asymptomatic mitral valve disease: a retrospective study of 141 cases.
TLDR
BNZ had beneficial effects in asymptomatic dogs other than C KC and KC affected by MVD with moderate-to-severe MR, and no effect of the BNZ treatment was observed in the CKC and KC population. Expand
Prospective evaluation of renal function in dogs with chronic mitral valve disease
TLDR
Looking at the prevalence of azotemia in CMVD dogs, data suggests a link between heart and kidney function (despite the authors didn’t excluded aged-related coexistence of organ damage) and no statistical evidence to support a difference in WRF parameters in dogs experiencing CHF and dogs not experiencing it is suggested. Expand
Effect of tepoxalin on renal function in healthy dogs receiving an angiotensin-converting enzyme inhibitor.
TLDR
It was concluded that tepoxalin did not alter renal function in healthy Beagle dogs receiving ACEI, and renal uptake and plasma clearance of 99mTc-DTPA were not significantly modified. Expand
Losartan versus enalapril in dogs asymptomatic carriers of myxomatous degeneration of mitral valve
TLDR
It is concluded that losartan acts similarly to enalapril in the initial treatment (first 56 days) of dogs with DMVM class Ib and II of the CHF. Expand
Azotemia and glomerular filtration rate in dogs with chronic valvular disease.
TLDR
Azotemia and renal impairment increase with the severity of congestive heart failure and are frequent findings in dogs with CVD and it remains to be shown if deterioration of renal function is a direct result of progression of the heart disease. Expand
Clinical evaluation of enalapril maleate and furosemide usage in dogs with degenerative myxomatous mitral valve, CHF functional class Ib
TLDR
Analysis of results showed that monotherapy based on enalapril maleate showed better efficiency of symptoms control in patients with CHF functional class Ib. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 30 REFERENCES
Functional renal insufficiency during long-term therapy with captopril and enalapril in severe chronic heart failure.
TLDR
The deterioration of renal function after converting-enzyme inhibition in heart failure is not a toxic or immunologic reaction to therapy but results from specific hemodynamic events that can be ameliorated by sodium repletion. Expand
Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
TLDR
Use of enalapril in combination withstandard treatment (diuretics with or without digoxin) appears to be beneficial over an extended period, compared with standard treatment alone. Expand
Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the Invasive Multicenter PROspective Veterinary Evaluation of Enalapril study. The IMPROVE Study Group.
  • D. Sisson
  • Medicine
  • Journal of veterinary internal medicine
  • 1995
TLDR
This study shows the beneficial hemodynamic and clinical effects of adding enalapril to conventional therapy for dogs with heart failure and significantly greater decreases in class of heart failure, pulmonary edema score, and mobility score relative to baseline. Expand
The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial.
  • J. Pouchelon
  • Medicine
  • Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology
  • 1999
TLDR
Benazepril extended the useful life-span of dogs with ISACHC class II and III heart failure (due to CVD) and was well tolerated. Expand
Controlled clinical evaluation of enalapril in dogs with heart failure: results of the Cooperative Veterinary Enalapril Study Group. The COVE Study Group.
  • J. Woodfield
  • Medicine
  • Journal of veterinary internal medicine
  • 1995
TLDR
The clinical efficacy and safety of enalapril were evaluated in dogs with moderate or severe heart failure and five dogs had to be removed from the study as a result of azotemia. Expand
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
TLDR
The angiotensin-converting--enzyme inhibitor enalapril significantly reduced the incidence of heart failure and the rate of related hospitalizations, as compared with the rates in the group given placebo, among patients with asymptomatic left ventricular dysfunction. Expand
Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
TLDR
The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions. Expand
Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
  • Medicine
  • The New England journal of medicine
  • 1987
TLDR
It is concluded that the addition of enalapril to conventional therapy in patients with severe congestive heart failure can reduce mortality and improve symptoms and a significant improvement in NYHA classification was observed in the enAlapril group. Expand
The effect of combined therapy with captopril, furosemide, and a sodium-restricted diet on serum electrolyte concentrations and renal function in normal dogs and dogs with congestive heart failure.
TLDR
Six of 10 dogs with congestive heart failure had at least one serum potassium concentration above the reference range sometime during the 5 weeks of observation, although the changes in the mean serum potassium concentrations were not statistically significant. Expand
Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors.
TLDR
In both groups of patients, in the absence of preexisting chronic uremia, recovery of renal function occurred without sequelae, even after an episode of acute tubular necrosis requiring dialysis, especially in older patients with congestive heart failure. Expand
...
1
2
3
...